IPRAS Journal Issue 7 CONTENTS
Total Page:16
File Type:pdf, Size:1020Kb
ISSN: 2241-1275 2 IPRAS Journal www.ipras.org Issue 7 CONTENTS • President’s Message . 5 • The PIP Breast Implant Scandal . 6 • General Secretary’s Message . 9 • Editor-in-Chief’s Message . 12 PAGE IPRAS Presentation from 14 Mr. Zacharias Kaplanidis (IPRAS • IPRAS Management office Report . 14 Executive Director) during the 48th Brazilian Congress of Plastic Surgery • Pioneers . 19 • Rising Star . 23 • Senior Ambassador . 24 • Humanitarian Works . 26 PAGE Humanitarian mission in Togo 36 • Surveys . 38 • National Associations’ & Plastic surgery organizations’ news . 50 • Historical Accounts . 63 • Certificate of Membership . 86 PAGE IPRAS Booth at the 1st Chinese 55 European Congress of Plastic • Congresses and Events . 90 Reconstructive and Aesthetic Surgery • National & co-opted societies future events . 114 • IPRAS website . 116 • Industry news . 117 • IPRAS Benefits for National Associations PAGE & individual members . 119 Historical Account of BAPRAS 77 Issue 7 www.ipras.org IPRAS Journal 3 AIMS AND SCOPE • To promote the art and science of plastic surgery • To further plastic surgery education and research • To protect the safety of the patient and the profession of Plastic, Reconstructive and Aesthetic Surgery • To relieve as far as it is possible the world from human violence or natural calamities through its humanitarian bodies • To encourage friendship among plastic surgeons and physicians of all countries 4 IPRAS Journal www.ipras.org Issue 7 PRESIDENT’SI P R A S JOURNAL MESSAGE Prof. Marita Eisemann-Klein President of IPRAS Dear colleagues, 2011 was the year of solidarity. For all those who missed registration: We decided Solidarity with our brave colleagues in Japan to offer online-participation. Just watch out for – while we felt powerless and helpless; solidarity further announcements! with our colleagues during the unrests in the Arab Keep monitoring at our other congress world, with our colleagues in countries which had announcements too: exciting topics and exciting to face crisis and disasters. locations are offered to you. Solidarity with patients in developing countries: There is a lot to look forward to this year! the number of missions and the number of There is also a lot to thank for during the past year: active collaborators in our humanitarian projects Thanks, from the bottom of my heart, to all of you increase considerably every year. Solidarity with patients who became victims of the PIP crime, is our latest challenge. These patients need all our support in their anxieties and in their search for implant removal at affordable expenses. Solidarity with our young residents: the evaluation form about training conditions will be launched soon and the first “Residents World Congress” Board of Directors will be held on November 1st , 2012 in Athens, Greece. There, we also plan to start the Academy for Residents Training. President Marita Eisenmann-Klein - Germany With the foundation of our Board of Trustees, we span the generations from the youngest to Presentation of Prof. Marita Eisenmann-Klein, General Secretary our senior role models, our giants, our heroes. Germany (IPRAS President) during the 48th Brazilian Nelson Piccolo - Brazil Recently we honoured our new Board of Congress of Plastic Surgery Treasurer Trustees members during the Brazilian Congress Bruce Cunningham - USA of Plastic Surgery: Ricardo Baroudi and Ivo who supported and assisted to develop IPRAS Pitanguy. They do not only stand for progress further – our humanity, our skills, our identity. Deputy General Secretary and technical excellency in plastic surgery, they Thank you for your confidence in the IPRAS Yi Lin Cao - China are charismatic philosophers as well. leadership and in me personally. It is such a pleasure to serve you as your Deputy General Secretary 2012 will be the year of pioneers in Plastic Brian Kinney - USA Surgery: Sydney Coleman has composed a President. fantastic program for the 1st International I wish you all a year of happiness and joy and full Deputy General Secretary of chances to develop your identity as a plastic Ahmed Noureldin - Egypt Congress of ISPRES in Rome, March 9-11, 2012. I am excited about the incredible amount of surgeon even further! Deputy General Secretary research programs in plastic surgery which will Andreas Yiacoumettis - Greece be presented in Rome. Cordially yours Parliamentarian We feel overwhelmed by the interest of our Norbert Pallua - Germany members in these innovative future oriented techniques. Executive Director I never before experienced having to close the Zacharias Kaplanidis - Greece registration two months prior to the start of a Marita Eisenmann-Klein congress! IPRAS President Issue 7 www.ipras.org IPRAS Journal 5 The PIP Breast Implant Scandal Chronology: thorough evaluations the French Society of Plastic Surgery decided to recommend a prophylactic explantation of all As early as in May 2000 the US Food and Drug Administration PIP implants. performed an inspection of the PIP production site in Finally, on December 23rd 2011, AFSSAPS also announced, Southern France. As a result of this inspection the sale of PIP that all PIP implants should be removed prophylactically. implants was stopped in the US. In a letter to Jean-Claude Most of the Health Authorities in Europe were hesitant to Mas, the owner of PIP, the FDA stated that the implants follow this recommendation, while plastic surgery societies were “adulterated” along with eleven other deviations from took the lead and recommended explantation. For example, the good manufacturing practices such as lack of sufficient German Association of Plastic, Reconstructive and Aesthetic investigation of deflation rate and failure of reporting 120 Surgeons convinced the German Cancer Society and the complaints. Gynaecological Society to hold a press conference together Whether the French Health Authority AFSSAPS was on January 6, 2012 to announce the recommendation for informed by the FDA, about the results of their inspection explantation. BfArM, the German Health Authorities followed or not, is unclear. and released a recommendation for explantation a few hours PIP must have started to exchange the medical grade silicone later. In many other countries, health authorities are still for industrial silicone probably in 2003. For a while, PIP hesitant to come up with a recommendation for explantation. used both types of gel but probably stopped using medical In a telephone conference of most of the European Health grade gel around 2005. From that time on, most likely they Authorities the majority recommended to wait for more data. only used industrial silicone. Roughly estimated: there must They claim that the potential risks of surgery and anaesthesia have been around 200 000 kilograms of industrial silicone might be higher than the potential risk of leaving the delivered to PIP and nobody considered this suspicious! implants in. There is an error in this logic: considering the Inspections were performed by TÜV Rheinland regularly but high failure rate of these implants, the probability, that these they all were announced ten days prior to their visit, which implants rupture within the next few years is extremely is in accordance with the requirements of the European high, which means that there is an almost 100% probability Medical Device Law. that these implants will have to be removed within the life Starting in 2008, more and more plastic surgeons reported span of the patient, but then under much worse conditions. a high failure rate in PIP implants. After an investigation by AFSSAPS, the French Health Authorities banned PIP What do we know about the health risks implants in spring of 2010. of PIP implants? Obviously the PIP implant stock or at least part of it was sold to the Netherlands and the distribution was continued We can only estimate the number of PIP implant patients by Rofil Medical under the name “M-implant”. to be around 500.000 worldwide. We know that PIP also When the Dutch health authorities found out that PIP and M produced other implants such as Testicle implants, buttock were identical, M-implants were banned in June 2010. implants and chest implants for men. We know that the Obviously, it was still possible to continue with the industrial gel which was used by PIP has been tested and distribution of M-implants. The last report we received was found not to be toxic. However, there are signs that the gel about an M-implant inserted as late as October 2011! The might have been manipulated after it was delivered to PIP. distributing company claims that this M-implant has nothing So, in fact, we do not know for sure whether or not it contains to do with PIP. Only the name would be the same, but the new toxic elements. This issue is still under investigation. product would be produced in Cyprus. The report from our We know that the rupture rate of these implants is colleagues in Cyprus revealed that there was no production considerably higher than the normal rupture rate for breast site in Cyprus. Subsequently, the company claimed that the implants which is considered to be 1%. production site was in Korea (North Korea??). Most of the Health Authorities declared rupture rates There are also hints that these products were sold to Middle between 5 and 10% for PIP, but the declarations vary. and South America. Hopefully through our well functioning We also know that the inflammatory reaction in PIP implants network with the help of our colleagues we can trace them seems to be unusually high in case of rupture. But even down. without rupture, patients may develop lymphadenopathy In November of 2011 a patient with PIP implants in France with painful and enlarged lymph nodes as far away as in died from Anaplastic Large Cell Lymphoma, which developed the groin, mediastinum and neck. Axillary lymph nodes are in the scar capsular tissue around the implants. enlarged in many patients. Subsequently, AFSSAPS released a warning that patients Although there were 16 cases of breast carcinoma reported with PIP implants should be examined regularly but they in France in PIP implant patients, there seems to be no did not suggest a prophylactic implant removal.